Same Indication

Ipilimumab vs Megestrol Acetate

Ipilimumab vs Megestrol Acetate: Overview

This comparison examines the pharmacological differences between Ipilimumab and Megestrol Acetate.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days.

Chemical Properties

Type: Ipilimumab β€” Antibody; Megestrol Acetate β€” Small molecule.